Vivo-Morpholino-Based Antiviral for SARS-CoV-2: Implications for Novel Therapies in the Treatment of Acute COVID-19 Disease

Therapeutic modalities designed specifically to inhibit COVID-19 infection and replication would limit progressive COVID-19-associated pulmonary disease in infected patients and prevent or limit systemic disease. If effective, antivirals could reduce viral transmission rates by reducing viral burden...

Descripción completa

Detalles Bibliográficos
Autores principales: Hildreth, James E. K., Moulton, Jon D., Alcendor, Donald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394971/
https://www.ncbi.nlm.nih.gov/pubmed/34440222
http://dx.doi.org/10.3390/biomedicines9081018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394971/
https://www.ncbi.nlm.nih.gov/pubmed/34440222
http://dx.doi.org/10.3390/biomedicines9081018

Ejemplares similares